Fast Food

Full Version: Harvard Drug Research Fraud and Cover-up: How Off-Label Profiteering Works
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
What is less understood is why drug manufacturers spend millions for research o-n off-label uses for their services and products - once the drug was submitted for approval uses that were never satisfied using the FDA.

Off-label use allows drug businesses to acquire 'through the rear door' what they could never, and I am talking about never, break free with by going straight to the FDA for approval for a new use of a solution - what is known today as an off-label use.

You would hope that researchers would not corrupt the testing of-a new, or off-label, usage of a drug to deal with kiddies by covering up their consulting fees from Big Pharma. But that is what happened.

Harvard Medicine Study Fraud and Cover-up: How Off-Label Profiteering Works

Medicine organization money corrupts and impacts research. That's certain. Discover new info on http://finance.texomashomepage.com/inerg...2%80%9Coff by visiting our pushing use with.

What is less comprehended is why drug companies spend millions for re-search o-n uses for their services and products - when the drug was submitted for approval uses that have been never cleared using the FDA.

Off-label use allows drug businesses to acquire 'through the rear door' what they could never, and I mean never, escape with by going right to the FDA for approval for a new use of the solution - what is known today as an off-label use.

You would hope that researchers would not corrupt the commercial analysis of-a new, or off-label, utilization of a drug to treat young ones by covering up their consulting expenses from Big Pharma. But that's what happened.

More important than what happened is excatly why it happened and at the bottom of this is a terrible mistake the U.S. has produced in enabling the exploitation of off-label use.

The devil is in the details, therefore here is the story because it has unfolded.

Leading Harvard teachers learning off-label uses, the gold mine of the drug industry, have violated National Institute of Health reporting requirements when over $10,000 is received from a subject organization, in line with the New York Times, 'Researchers Neglect to Reveal Drug Pay' June 8, 2008. http://www.nytimes.com/2008/06/08/us/08c...rry&st=cse isn't enough.

If Harvard doesn't fire them, it'll be complicit in the cover-up.

Put them off campus. Ring the bell loud and clear that no matter how renown or outstanding, if you don't play by the principles, you can not play at all. And the NIH must forever exclude them from receiving grants.

Do not throw out the child with the bath water. Once proper punishment has been offered, give a chance to these experts to polish their damaged reputations. Allow them to conduct research under the guidance of a responsible supervisor who understands that 'veritas,' means truth, reliability, honesty, and uprightness and that it's more than just a motto.

Onward. Navigating To http://finance.pahomepage.com/inergize.p...2%80%9Coff probably provides lessons you might tell your brother.

Richard Alexander

http://www.alexanderinjury.com.
Reference URL's